Novel role of copper transport protein antioxidant-1 in neointimal formation after vascular injury

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 33, Issue 4, 2013, Pages 805-813

  Kohno, Takashi ^a,b   Urao, Norifumi ^a   Ashino, Takashi ^a,c   Sudhahar, Varadarajan ^a   McKinney, Ronald D ^a,b   Hamakubo, Takao ^d   Iwanari, Hiroko ^d   Ushio Fukai, Masuko ^a   Fukai, Tohru ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

^c SHOWA UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

antioxidant 1; ATP7A; copper transport protein; migration; platelet derived growth factor; vascular injury; vascular smooth muscle cells

Indexed keywords

CARRIER PROTEIN; COPPER TRANSPORT PROTEIN ANTIOXIDANT 1; MENKES PROTEIN; PLATELET DERIVED GROWTH FACTOR; PROTEIN LYSINE 6 OXIDASE; RAC1 PROTEIN; SMALL INTERFERING RNA; THIOGLYCOLIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL INJURY; CELL INFILTRATION; CELL MIGRATION; CONTROLLED STUDY; DOWNSTREAM PROCESSING; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FEMORAL ARTERY; INFLAMMATORY CELL; LAMELLIPODIUM; MACROPHAGE; MOUSE; NEOINTIMA; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ADENOSINE TRIPHOSPHATASES; ANIMALS; CATION TRANSPORT PROTEINS; CELL MOVEMENT; CELLS, CULTURED; COPPER; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; FEMORAL ARTERY; HUMANS; MACROPHAGES, PERITONEAL; MICE; MICE, KNOCKOUT; MOLECULAR CHAPERONES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; NEUROPEPTIDES; PERITONITIS; PLATELET-DERIVED GROWTH FACTOR; PROTEIN TRANSPORT; PROTEIN-LYSINE 6-OXIDASE; PSEUDOPODIA; RAC GTP-BINDING PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RNA INTERFERENCE; THIOGLYCOLATES; TIME FACTORS; TRANSFECTION; UP-REGULATION; VASCULAR SYSTEM INJURIES;

EID: 84875367483     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.112.300862     Document Type: Article

References (43)

1. Raines EW. PDGF and cardiovascular disease. Cytokine Growth Factor Rev. 2004;15:237-254.
2. Schwartz SM. Smooth muscle migration in atherosclerosis and restenosis. J Clin Invest. 1997;100(suppl 11):S87-S89.
3. Gerthoffer WT. Mechanisms of vascular smooth muscle cell migration. Circ Res. 2007;100:607-621.
4. Schlief ML, Gitlin JD. Copper homeostasis in the CNS: a novel link between the NMDA receptor and copper homeostasis in the hippocampus. Mol Neurobiol. 2006;33:81-90.
5. Brewer GJ. Anticopper therapy against cancer and diseases of inflammation and fibrosis. Drug Discov Today. 2005;10:1103-1109.
6. Brewer GJ. Iron and copper toxicity in diseases of aging, particularly atherosclerosis and Alzheimer's disease. Exp Biol Med (Maywood). 2007;232:323-335.
7. Ferns GA, Lamb DJ, Taylor A. The possible role of copper ions in atherogenesis: the Blue Janus. Atherosclerosis. 1997;133:139-152.
8. Saari JT, Schuschke DA. Cardiovascular effects of dietary copper deficiency. Biofactors. 1999;10:359-375.
9. Klevay LM. Cardiovascular disease from copper deficiency-a history. J Nutr. 2000;130(suppl 2S):489S-492S.
10. Strain JJ. Newer aspects of micronutrients in chronic disease: copper. Proc Nutr Soc. 1994;53:583-598.
11. Schümann K, Classen HG, Dieter HH, König J, Multhaup G, Rükgauer M, Summer KH, Bernhardt J, Biesalski HK. Hohenheim consensus workshop: copper. Eur J Clin Nutr. 2002;56:469-483.
12. Stadler N, Lindner RA, Davies MJ. Direct detection and quantification of transition metal ions in human atherosclerotic plaques: evidence for the presence of elevated levels of iron and copper. Arterioscler Thromb Vasc Biol. 2004;24:949-954.
13. Völker W, Dorszewski A, Unruh V, Robenek H, Breithardt G, Buddecke E. Copper-induced inflammatory reactions of rat carotid arteries mimic restenosis/arteriosclerosis-like neointima formation. Atherosclerosis. 1997;130:29-36.
14. Mandinov L, Mandinova A, Kyurkchiev S, Kyurkchiev D, Kehayov I, Kolev V, Soldi R, Bagala C, de Muinck ED, Lindner V, Post MJ, Simons M, Bellum S, Prudovsky I, Maciag T. Copper chelation represses the vascular response to injury. Proc Natl Acad Sci USA. 2003;100: 6700-6705.
15. Ashino T, Sudhahar V, Urao N, Oshikawa J, Chen GF, Wang H, Huo Y, Finney L, Vogt S, McKinney RD, Maryon EB, Kaplan JH, Ushio-Fukai M, Fukai T. Unexpected role of the copper transporter ATP7A in PDGF-induced vascular smooth muscle cell migration. Circ Res. 2010;107:787-799.
16. Rae TD, Schmidt PJ, Pufahl RA, Culotta VC, O'Halloran TV. Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase. Science. 1999;284:805-808.
17. Kim BE, Nevitt T, Thiele DJ. Mechanisms for copper acquisition, distribution and regulation. Nat Chem Biol. 2008;4:176-185.
18. Strausak D, La Fontaine S, Hill J, Firth SD, Lockhart PJ, Mercer JF. The role of GMXCXXC metal binding sites in the copper-induced redistribution of the Menkes protein. J Biol Chem. 1999;274:11170-11177.
19. Jeney V, Itoh S, Wendt M, Gradek Q, Ushio-Fukai M, Harrison DG, Fukai T. Role of antioxidant-1 in extracellular superoxide dismutase function and expression. Circ Res. 2005;96:723-729.
20. Qin Z, Itoh S, Jeney V, Ushio-Fukai M, Fukai T. Essential role for the Menkes ATPase in activation of extracellular superoxide dismutase: implication for vascular oxidative stress. FASEB J. 2006;20:334-336.
21. Itoh S, Kim HW, Nakagawa O, Ozumi K, Lessner SM, Aoki H, Akram K, McKinney RD, Ushio-Fukai M, Fukai T. Novel role of antioxidant-1 (Atox1) as a copper-dependent transcription factor involved in cell proliferation. J Biol Chem. 2008;283:9157-9167.
22. Rodríguez C, Martínez-González J, Raposo B, Alcudia JF, Guadall A, Badimon L. Regulation of lysyl oxidase in vascular cells: lysyl oxidase as a new player in cardiovascular diseases. Cardiovasc Res. 2008;79:7-13.
23. Segal BH, Kuhns DB, Ding L, Gallin JI, Holland SM. Thioglycollate peritonitis in mice lacking C5, 5-lipoxygenase, or p47(phox): complement, leukotrienes, and reactive oxidants in acute inflammation. J Leukoc Biol. 2002;71:410-416.
24. Ridley AJ. Rho GTPases and cell migration. J Cell Sci. 2001;114(pt 15):2713-2722.
25. Alvarez HM, Xue Y, Robinson CD, Canalizo-Hernández MA, Marvin RG, Kelly RA, Mondragón A, Penner-Hahn JE, O'Halloran TV. Tetrathiomolybdate inhibits copper trafficking proteins through metal cluster formation. Science. 2010;327:331-334.
26. Brewer GJ. Tetrathiomolybdate anticopper therapy for Wilson's disease inhibits angiogenesis, fibrosis and inflammation. J Cell Mol Med. 2003;7:11-20.
27. Goodman VL, Brewer GJ, Merajver SD. Copper deficiency as an anticancer strategy. Endocr Relat Cancer. 2004;11:255-263.
28. Hung IH, Casareno RL, Labesse G, Mathews FS, Gitlin JD. HAH1 is a copper-binding protein with distinct amino acid residues mediating copper homeostasis and antioxidant defense. J Biol Chem. 1998;273:1749-1754.
29. Lin SJ, Pufahl RA, Dancis A, O'Halloran TV, Culotta VC. A role for the Saccharomyces cerevisiae ATX1 gene in copper trafficking and iron transport. J Biol Chem. 1997;272:9215-9220.
30. Itoh S, Ozumi K, Kim HW, Nakagawa O, McKinney RD, Folz RJ, Zelko IN, Ushio-Fukai M, Fukai T. Novel mechanism for regulation of extracellular SOD transcription and activity by copper: role of antioxidant-1. Free Radic Biol Med. 2009;46:95-104.
31. Kelner GS, Lee M, Clark ME, Maciejewski D, McGrath D, Rabizadeh S, Lyons T, Bredesen D, Jenner P, Maki RA. The copper transport protein Atox1 promotes neuronal survival. J Biol Chem. 2000;275:580-584.
32. Walker JM, Tsivkovskii R, Lutsenko S. Metallochaperone Atox1 transfers copper to the NH2-terminal domain of the Wilson's disease protein and regulates its catalytic activity. J Biol Chem. 2002;277:27953-27959.
33. Hamza I, Faisst A, Prohaska J, Chen J, Gruss P, Gitlin JD. The metallochaperone Atox1 plays a critical role in perinatal copper homeostasis. Proc Natl Acad Sci USA. 2001;98:6848-6852.
34. Rönnstrand L, Heldin CH. Mechanisms of platelet-derived growth factor-induced chemotaxis. Int J Cancer. 2001;91:757-762.
35. Muller PA, Klomp LW. ATOX1: a novel copper-responsive transcription factor in mammals? Int J Biochem Cell Biol. 2009;41:1233-1236.
36. San Martín A, Griendling KK. Redox control of vascular smooth muscle migration. Antioxid Redox Signal. 2010;12:625-640.
37. Ozumi K, Sudhahar V, Kim HW, Chen GF, Kohno T, Finney L, Vogt S, McKinney RD, Ushio-Fukai M, Fukai T. Role of copper transport protein antioxidant 1 in angiotensin II-induced hypertension: a key regulator of extracellular superoxide dismutase. Hypertension. 2012;60: 476-486.
38. Nuthakki VK, Fleser PS, Malinzak LE, Seymour ML, Callahan RE, Bendick PJ, Zelenock GB, Shanley CJ. Lysyl oxidase expression in a rat model of arterial balloon injury. J Vasc Surg. 2004;40: 123-129.
39. Lucero HA, Ravid K, Grimsby JL, Rich CB, DiCamillo SJ, Mäki JM, Myllyharju J, Kagan HM. Lysyl oxidase oxidizes cell membrane proteins and enhances the chemotactic response of vascular smooth muscle cells. J Biol Chem. 2008;283:24103-24117.
40. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868-874.
41. Babu U, Failla ML. Copper status and function of neutrophils are reversibly depressed in marginally and severely copper-deficient rats. J Nutr. 1990;120:1700-1709.
42. Cerone S, Sansinanea A, Streitenberger S, García C, Auza N. Bovine monocyte-derived macrophage function in induced copper deficiency. Gen Physiol Biophys. 2000;19:49-58.
43. White C, Lee J, Kambe T, Fritsche K, Petris MJ. A role for the ATP7A copper-transporting ATPase in macrophage bactericidal activity. J Biol Chem. 2009;284:33949-33956.